BiotechTube
Home/Vincerx Pharma/Alexander C. Schmidt, Ph.D.
AC

Alexander C. Schmidt, Ph.D.

Chief Development Officer

Vincerx Pharma

Therapeutic Areas

Oncology

Vincerx Pharma Pipeline

DrugIndicationPhase
VIP236Metastatic Solid TumorsPhase 1
VIP943Relapsed/Refractory Hematologic MalignanciesPhase 1
Enitociclib (VIP152)Non-Hodgkin Lymphoma (NHL)Phase 1
BCL-2 Inhibitor ProgramOncologyPreclinical

Leadership Team at Vincerx Pharma

AH
Ahmed Hamdy, M.D.
Chief Executive Officer
MM
Michael Morris, M.D.
Chief Medical Officer
JH
John H. Lee, M.D., Ph.D.
Former Chief Medical Officer
View full Vincerx Pharma profile